Business Wire

NY-CELONIS

14.5.2024 08:01:35 CEST | Business Wire | Press release

Share
Celonis Recognized as a Leader for Second Consecutive Year in 2024 Gartner® Magic Quadrant™ for Process Mining Platforms

Celonis, the global leader in Process Mining, announced today that it has been named a Leader in the Gartner Magic Quadrant for Process Mining Platforms for the second time since the category's inception last year. Celonis was evaluated and placed in the Leaders’ Quadrant, being positioned highest on the Ability to Execute axis and advancing to the furthest spot on the Completeness of Vision axis once again.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240513067064/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Celonis is a Leader in the 2024 Gartner Magic Quadrant for Process Mining Platforms, placed highest on the Ability to Execute and highest on Completeness of Vision. (Graphic: Business Wire)

“The pace of change keeps accelerating - new technologies keep emerging, customer expectations keep rising, and the need for greater efficiency keeps increasing. To succeed, organizations need solutions that help them address all these demands, and most importantly create meaningful value,” said Alex Rinke, co-CEO and co-founder of Celonis. “Celonis gives companies a common language for how their business runs and provides the context to enable technologies like AI and automation to become effective. For us, being named a Leader for the second consecutive year in the Gartner Magic Quadrant for Process Mining Platforms reinforces our commitment to make processes work for people, companies and the planet. We are proud to receive this recognition and will continue to build the future of process intelligence together with our customers, partners and fellow Celonauts who have embraced our vision and keep pushing process mining to realize its full potential.”

“Process mining has become an essential enterprise solution for adapting to an uncertain world and driving transformation at speed and scale,” said Daniel de Rooij, SVP Digital Transformation and CIO Hygiene at Reckitt, a global consumer products company with well-known brands such as Finish dishwasher tablets, Lysol disinfectant, and Nurofen painkillers. “With advancements like object-centric process mining and the Process Intelligence Graph, Celonis’ platform provides us with the unique process intelligence that we need to optimize IT operations, deliver value to the business faster, and drive disruptive innovation with emerging technologies like generative AI.”

Celonis enables customers to identify and capture hidden value, empower their people with actionable insights, and help them more effectively leverage technologies like AI and automation to optimize their processes. At the core of the Celonis Platform is the Process Intelligence Graph (PI Graph), an extensible digital twin of the business based on a standardized, object-centric data model. This twin is system-agnostic and without bias. The PI Graph adds business context to this process digital twin with out-of-the-box KPI definitions and improvement opportunities, such as how delivery blocks impact on-time delivery rate. Sitting at the heart of the Celonis platform, the PI Graph allows us to create capabilities that embed AI in ready-to-use solutions. For example, the Process Copilot chatbot turns natural language requests into process insights, and the AI-powered Duplicate Checker App helps keep customers from paying invoices twice. Using our Machine Learning (ML) Workbench customers and partners can create their own AI solutions in Celonis or feed data into their existing AI tools using our Intelligence API.

The platform also provides advanced process modeling functionality. In 2023, Celonis acquired Symbio, a provider of AI-driven Business Process Management (BPM) software. The integration of Symbio’s capabilities into the Celonis platform enables customers to not only mine their processes and identify value opportunities, but also design their ideal process using a modern, AI-assisted process modeling solution. Customers can also ensure their processes stay on the straight and narrow with the Process Adherence Manager and track the business impact of their process improvement work with the Transformation Hub.

Notes to editors

The 2024 Gartner Magic Quadrant on Process Mining Platforms is available here.
Find more information on Process Mining and the Celonis Process Intelligence Platform here.

Gartner, Magic Quadrant for Process Mining Platforms, Marc Kerremans, David Sudgen, Nick Duffy, 29 April 2024

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Celonis

Since 2011, Celonis has helped thousands of the world’s largest and most esteemed companies yield immediate cash impact, radically improve customer experience, and reduce carbon emissions. Its Process Intelligence platform uses industry-leading process mining technology and AI to present companies with a living digital twin of their end-to-end processes. For the first time, everyone in an organization has a common language for how the business runs, visibility into where value is hiding, and the ability to capture it. Celonis is headquartered in Munich, Germany and New York City, USA with more than 20 offices worldwide.

© 2024 Celonis SE. All rights reserved. Celonis and the Celonis “droplet” logo are trademarks or registered trademarks of Celonis SE in Germany and other jurisdictions. All other product and company names are trademarks or registered trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240513067064/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release

Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release

New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel

HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 17:30:00 CEST | Press release

HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye